Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Instagram Outage Disrupts Thousands of U.S. Users 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Albany – NY, Sept. 28, 2017 -- Celebrity Endorsement of Awareness Campaigns Uptakes Adoption among Young Adults
Among the key factors driving the global contraceptives market is the increasing number of awareness campaigns that propagate contraceptives to be the effective method to prevent unintended pregnancies, which is leading to their increased adoption among young and adolescent population in both developed and developing countries. The campaigns that are generally undertaken by government agencies and NGOs are endorsed by celebrities, which is favoring the use of contraceptives among young adults who have the mindset to imitate famous people.
As per estimates by Transparency Market Research, the global contraceptives market will reach a valuation of US$37,242.7 mn by the end of 2025 from a valuation of US$22,050.0 mn in 2016 at a CAGR of 6.1% between 2017 and 2025.
View Full Report at https://www.transparencymarketresearch.com/contraceptives-market.html
Further, the awareness campaigns also offer expert guidance about adoption of most effective method of contraception depending on individual need. Woman’s overall health, age, frequency of sexual activity, desire to have children in future, and family history are some of the factors that gynecologists look into before advising the method of contraception.
In developing regions, especially among the urban population, modern education and career aspirations have been crucial factors for the increasing adoption of contraceptives. Increasing number of women in the workforce and nuclear family setups are leading to increasing use of contraceptives for delayed pregnancies. Couples are increasingly seeking expert help for advice regarding the method of contraception to be adopted and guidance regarding family planning that suit their need.
Request to View Sample Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344
Apart from this, the rising prevalence of sexually transmitted diseases is also leading to the uptake of contraceptives. This is because contraceptives such as condoms and topical contraceptive patch are effective to prevent sexually transmitted diseases such as AIDS in the event of sexual activity with multiple partners.
Lastly, development of novel contraceptive products by leading key players is also acting in favor of the global contraceptives market.
Amongst the key product types, contraceptive devices holds dominance with the segment holding 53.2% market share in 2016. Hospital pharmacy leads among the key distribution channels on account of a number of favorable factors. Geography-wise, North America holds lucrative growth prospects among other key markets for contraceptives. However, Asia Pacific is poised to display the leading growth rate over the forecast period.
Request to download and view full ToC - https://www.transparencymarketresearch.com/report-toc/344
Chances of Side Effects Challenge Growth
On the downside, side effects associated with hormonal contraception is slowing the adoption of these products among wary consumers. Rising infertility is also proving to be a major restraint on the growth of contraceptives market.
The global contraceptives market displays intense competition with the presence of a multitude of key players that operate globally, says Transparency Market Research (TMR) in a new study. Despite this, Bayer AG stood as the clear leader in 2016 attributed to its diverse product portfolio and strong global presence. This has led other key players to develop novel contraception products for competitive gains.
Global Contraceptives Market Report is available @ US$ 5795
Some other prominent participants in the global contraceptives market are Cipla Inc., Merck Co. Inc., Mankind Pharma, Teva Pharmaceutical Industries Ltd., Janssen Pharmaceutical Company, Allergan plc, HLL Lifecare Limited, Pfizer Inc., Mithra Pharmaceuticals, and Reckitt Benckiser plc among others.
About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research State Tower 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com
